Generic Name and Formulations:
Dimethyl sulfoxide 50%; aqueous soln for intravesical administration.
- Glatiramer Acetate Associated With Long-Term Disability Improvements in MS
- Increased Risk for Suicide Attempts in Patients With Status Migrainosus
- Headache Specialists Dissatisfied With Emergency Department Headache Care
Indications for RIMSO-50:
Symptomatic relief of interstitial cystitis.
1 bottle (50mL) via catheter or aseptic syringe directly into the bladder for 15 minutes every 2 weeks until asymptomatic; then may increase dosing interval. To reduce bladder spasm: use a local anesthetic gel + an oral analgesics or belladona and opium suppositories before administration.
Refer for full eye evaluation, including slit lamp, at baseline and periodically. Monitor CBC, liver and renal function every 6 months. Urinary tract malignancy. Pregnancy (Cat.C). Nursing mothers.
May potentiate other concomitantly administered medications.
Garlic-like taste or odor (may last for 72 hours), local discomfort, transient chemical cystitis.
Neurology Advisor Articles
- Excess Abdominal Obesity Linked to Severe Disability in Multiple Sclerosis
- Change in Dietary Patterns Over 5 Years in Early Multiple Sclerosis
- High-Dose Biotin May Be an Effective Treatment for Progressive MS
- Biobank Data Suggest Vitamin D Reduces Risk for Multiple Sclerosis
- Poor Functional Outcomes Tied to Depressive Symptoms in Multiple Sclerosis
- Managing Status Epilepticus in Palliative Care: Accounting for Patient and Family Experience
- Oxygen Desaturation Index Predicts AFib Risk in Ischemic Stroke
- Opioid Use Down With 'Enhanced Recovery After Surgery' Program
- Popular Heroin Inhalation Method Tied to Leukoencephalopathy
- Erenumab Superior to Placebo for Reducing Migraine Disability, Improving HRQoL